Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 22 | 2015 | 2207 | 2.760 |
Why?
|
| Puerto Rico | 28 | 2017 | 1352 | 1.640 |
Why?
|
| Acquired Immunodeficiency Syndrome | 9 | 2015 | 214 | 1.580 |
Why?
|
| Hepatitis C | 4 | 2013 | 120 | 1.310 |
Why?
|
| Risk-Taking | 5 | 2015 | 435 | 1.290 |
Why?
|
| Antiretroviral Therapy, Highly Active | 6 | 2015 | 219 | 1.220 |
Why?
|
| Multimedia | 3 | 2013 | 16 | 0.890 |
Why?
|
| Viral Load | 5 | 2015 | 300 | 0.890 |
Why?
|
| CD4 Lymphocyte Count | 5 | 2015 | 185 | 0.810 |
Why?
|
| Female | 36 | 2017 | 19873 | 0.730 |
Why?
|
| Male | 31 | 2015 | 18870 | 0.680 |
Why?
|
| Adult | 25 | 2017 | 11034 | 0.660 |
Why?
|
| Substance Abuse, Intravenous | 3 | 2013 | 123 | 0.650 |
Why?
|
| Colorectal Neoplasms | 3 | 2015 | 413 | 0.650 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2013 | 790 | 0.610 |
Why?
|
| Middle Aged | 20 | 2017 | 9642 | 0.600 |
Why?
|
| Adolescent Behavior | 3 | 2015 | 243 | 0.600 |
Why?
|
| Patient Compliance | 2 | 2015 | 202 | 0.580 |
Why?
|
| Pancytopenia | 1 | 2015 | 3 | 0.560 |
Why?
|
| Humans | 39 | 2017 | 34853 | 0.560 |
Why?
|
| Colonoscopy | 1 | 2015 | 98 | 0.530 |
Why?
|
| School Health Services | 1 | 2015 | 77 | 0.520 |
Why?
|
| Cohort Studies | 9 | 2015 | 1422 | 0.510 |
Why?
|
| Mammography | 1 | 2015 | 176 | 0.500 |
Why?
|
| Anemia | 1 | 2014 | 45 | 0.490 |
Why?
|
| Genes, ras | 1 | 2013 | 22 | 0.480 |
Why?
|
| ras Proteins | 1 | 2013 | 49 | 0.470 |
Why?
|
| Body Mass Index | 2 | 2014 | 775 | 0.460 |
Why?
|
| Risk Reduction Behavior | 2 | 2013 | 121 | 0.450 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 292 | 0.450 |
Why?
|
| Anti-HIV Agents | 2 | 2015 | 394 | 0.440 |
Why?
|
| Aged | 12 | 2015 | 6448 | 0.440 |
Why?
|
| Mass Screening | 1 | 2015 | 427 | 0.420 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 229 | 0.420 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2011 | 9 | 0.410 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2011 | 41 | 0.400 |
Why?
|
| Prevalence | 7 | 2015 | 1425 | 0.390 |
Why?
|
| Health Education | 1 | 2013 | 304 | 0.380 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2010 | 13 | 0.370 |
Why?
|
| Mutation | 1 | 2013 | 1023 | 0.350 |
Why?
|
| Prospective Studies | 6 | 2017 | 1353 | 0.340 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 446 | 0.320 |
Why?
|
| Computer-Assisted Instruction | 1 | 2008 | 27 | 0.320 |
Why?
|
| Adolescent | 8 | 2015 | 5035 | 0.310 |
Why?
|
| Cross-Sectional Studies | 7 | 2013 | 2561 | 0.310 |
Why?
|
| Receptors, Immunologic | 3 | 2014 | 59 | 0.300 |
Why?
|
| Proportional Hazards Models | 3 | 2014 | 423 | 0.300 |
Why?
|
| Factor V | 1 | 2006 | 1 | 0.290 |
Why?
|
| Thrombophilia | 1 | 2006 | 3 | 0.290 |
Why?
|
| Pilot Projects | 4 | 2015 | 628 | 0.290 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2006 | 5 | 0.290 |
Why?
|
| Neoplasms, Second Primary | 1 | 2006 | 14 | 0.290 |
Why?
|
| Suicide, Attempted | 1 | 2008 | 88 | 0.290 |
Why?
|
| Point Mutation | 1 | 2006 | 88 | 0.280 |
Why?
|
| Sex Factors | 5 | 2015 | 859 | 0.280 |
Why?
|
| Risk Factors | 8 | 2015 | 3414 | 0.270 |
Why?
|
| Comorbidity | 4 | 2014 | 606 | 0.260 |
Why?
|
| Health Care Reform | 1 | 2005 | 31 | 0.260 |
Why?
|
| Young Adult | 6 | 2015 | 4012 | 0.260 |
Why?
|
| Longitudinal Studies | 3 | 2015 | 841 | 0.250 |
Why?
|
| Substance-Related Disorders | 2 | 2017 | 685 | 0.250 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 570 | 0.240 |
Why?
|
| Mortality | 1 | 2005 | 150 | 0.230 |
Why?
|
| Chi-Square Distribution | 3 | 2008 | 213 | 0.230 |
Why?
|
| Anti-Retroviral Agents | 2 | 2015 | 139 | 0.230 |
Why?
|
| Social Class | 1 | 2005 | 228 | 0.230 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 336 | 0.210 |
Why?
|
| Familial Mediterranean Fever | 1 | 2010 | 1 | 0.190 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2010 | 1 | 0.190 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2010 | 2 | 0.190 |
Why?
|
| Program Evaluation | 2 | 2013 | 316 | 0.190 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 2333 | 0.180 |
Why?
|
| Incidence | 3 | 2013 | 882 | 0.170 |
Why?
|
| Neoplasms | 1 | 2008 | 1033 | 0.160 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 1003 | 0.160 |
Why?
|
| Treatment Outcome | 4 | 2017 | 1349 | 0.160 |
Why?
|
| Health Services for the Aged | 1 | 1997 | 17 | 0.160 |
Why?
|
| Primary Prevention | 1 | 1997 | 57 | 0.150 |
Why?
|
| Preventive Health Services | 1 | 1997 | 61 | 0.150 |
Why?
|
| Logistic Models | 3 | 2015 | 894 | 0.150 |
Why?
|
| Viremia | 1 | 2015 | 40 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2010 | 628 | 0.130 |
Why?
|
| Time Factors | 3 | 2015 | 1681 | 0.130 |
Why?
|
| Unemployment | 1 | 2014 | 23 | 0.130 |
Why?
|
| Leukocyte Count | 1 | 2014 | 74 | 0.130 |
Why?
|
| Chest Pain | 1 | 2014 | 36 | 0.120 |
Why?
|
| Acute Coronary Syndrome | 1 | 2014 | 35 | 0.120 |
Why?
|
| Books | 1 | 2013 | 4 | 0.120 |
Why?
|
| Blood Platelets | 2 | 2014 | 74 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 44 | 0.120 |
Why?
|
| Survival Rate | 1 | 2014 | 310 | 0.120 |
Why?
|
| Quality of Life | 1 | 2017 | 459 | 0.110 |
Why?
|
| Canada | 1 | 2013 | 121 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 248 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2008 | 1961 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2017 | 343 | 0.100 |
Why?
|
| Poverty | 1 | 2013 | 316 | 0.100 |
Why?
|
| Kidney Function Tests | 1 | 2010 | 30 | 0.090 |
Why?
|
| Demography | 1 | 2010 | 167 | 0.090 |
Why?
|
| Homosexuality, Male | 1 | 2015 | 438 | 0.090 |
Why?
|
| Platelet Aggregation | 1 | 2009 | 17 | 0.090 |
Why?
|
| Actins | 1 | 2010 | 142 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2009 | 46 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2008 | 39 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 2008 | 63 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2008 | 196 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 269 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2010 | 358 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2010 | 296 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2008 | 322 | 0.070 |
Why?
|
| Wilms Tumor | 1 | 2006 | 4 | 0.070 |
Why?
|
| Pedigree | 1 | 2006 | 64 | 0.070 |
Why?
|
| Hepacivirus | 1 | 2006 | 59 | 0.070 |
Why?
|
| Health Behavior | 1 | 2010 | 491 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2006 | 65 | 0.070 |
Why?
|
| HIV | 1 | 2006 | 97 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1426 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 465 | 0.060 |
Why?
|
| Health Status Disparities | 1 | 2010 | 583 | 0.060 |
Why?
|
| United States | 1 | 2013 | 3894 | 0.060 |
Why?
|
| Hypertension | 1 | 2010 | 770 | 0.060 |
Why?
|
| Solubility | 2 | 2014 | 115 | 0.050 |
Why?
|
| Politics | 1 | 2010 | 35 | 0.050 |
Why?
|
| Geriatric Assessment | 1 | 1997 | 52 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 1997 | 76 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 1997 | 207 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 28 | 0.030 |
Why?
|
| Hospitalization | 1 | 1997 | 370 | 0.030 |
Why?
|
| Foodborne Diseases | 1 | 2013 | 22 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 120 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 147 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 188 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 1007 | 0.030 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2012 | 16 | 0.030 |
Why?
|
| Caribbean Region | 1 | 2012 | 63 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2012 | 101 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1056 | 0.030 |
Why?
|
| Body Weight | 1 | 2012 | 404 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 608 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2009 | 23 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 209 | 0.020 |
Why?
|
| Mice | 2 | 2010 | 5668 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 472 | 0.020 |
Why?
|
| Sepsis | 1 | 2009 | 76 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 200 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 485 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 435 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 897 | 0.020 |
Why?
|
| Protein Binding | 1 | 2009 | 913 | 0.020 |
Why?
|
| Inflammation | 1 | 2009 | 577 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 1530 | 0.020 |
Why?
|
| Animals | 2 | 2010 | 14307 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 965 | 0.010 |
Why?
|